For over 5 years, Arthur has been professionally covering video games, writing guides and walkthroughs. His passion for video games began at age 10 in 2010 when he first played Gothic, an immersive ...

TAMPA, Fla. (April 22, 2026) – Older adults and technology haven’t always had the smoothest relationship. From learning to use email to operating smartphones, each new wave has brought fresh ...

It’s a simple thing we encounter many times every single week – often while in a hurry. You pull up at a parking spot, scan a QR code and pay within seconds. Or you sit down at a cafe, scan a code to ...

Anyone can code using AI. But it might come with a hidden cost. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. Over the past year, AI systems have ...

The entire source code for Anthropic’s Claude Code command line interface application (not the models themselves) has been leaked and disseminated, apparently due ...

Today, you can use Google Messages for web using QR code pairing or Google Account sign-in. The original login method will soon go away. Opening messages.google.com ...

QR codes are built into the modern internet experience. You point your phone at the square with a strange pattern, and it'll load a website on your phone, which will offer specific information. But ...

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...